Literature DB >> 21597459

E3 ubiquitin ligase Hades negatively regulates the exonuclear function of p53.

J H Jung1, S Bae, J Y Lee, S R Woo, H J Cha, Y Yoon, K-S Suh, S-J Lee, I-C Park, Y-W Jin, K-H Lee, S An, J H Lee.   

Abstract

Following DNA damage, p53 translocates to the cytoplasm and mitochondria, where it triggers transcription-independent apoptosis by binding to Bcl-2 family proteins. However, little is known about how this exonuclear function of p53 is regulated. Here, we identify and characterize a p53-interacting protein called Hades, an E3 ligase that interacts with p53 in the mitochondria. Hades reduces p53 stability via a mechanism that requires its RING-finger domain with ubiquitin ligase activity. Hades polyubiquitinates p53 in vitro independent of Mdm2 and targets a critical lysine residue in p53 (lysine 24) distinct from those targeted by Mdm2. Hades inhibits a p53-dependent mitochondrial cell death pathway by inhibiting p53 and Bcl-2 interactions. These findings show that Hades-mediated p53 ubiquitination is a novel mechanism for negatively regulating the exonuclear function of p53.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597459      PMCID: PMC3214910          DOI: 10.1038/cdd.2011.57

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  35 in total

1.  Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells.

Authors:  G Shaulsky; A Ben-Ze'ev; V Rotter
Journal:  Oncogene       Date:  1990-11       Impact factor: 9.867

2.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

Authors:  J Martinez; I Georgoff; J Martinez; A J Levine
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

5.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.

Authors:  C Caelles; A Helmberg; M Karin
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

7.  A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.

Authors:  Hyeon-Ok Jin; Sung-Keum Seo; Sang-Hyeok Woo; Hyung-Chahn Lee; Eun-Sung Kim; Doo-Hyun Yoo; Su-Jae Lee; Sungkwan An; Tae-Boo Choe; Jong-Il Kim; Seok-Il Hong; Chang-Hun Rhee; In-Chul Park
Journal:  Lung Cancer       Date:  2008-02-20       Impact factor: 5.705

8.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.

Authors:  A J Wagner; J M Kokontis; N Hay
Journal:  Genes Dev       Date:  1994-12-01       Impact factor: 11.361

9.  Induction of apoptosis in HeLa cells by trans-activation-deficient p53.

Authors:  Y Haupt; S Rowan; E Shaulian; K H Vousden; M Oren
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

10.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

View more
  20 in total

1.  The RING domain of mitochondrial E3 ubiquitin ligase 1 and its complex with Ube2D2: crystallization and X-ray diffraction.

Authors:  Sang Ok Lee; Chong Kil Lee; Kyoung Seok Ryu; Seung Wook Chi
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-01-01       Impact factor: 1.056

Review 2.  A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.

Authors:  Ayumu Sugiura; Gian-Luca McLelland; Edward A Fon; Heidi M McBride
Journal:  EMBO J       Date:  2014-08-08       Impact factor: 11.598

3.  The Arabidopsis E3 Ubiquitin Ligase SP1 Targets to Chloroplasts, Peroxisomes, and Mitochondria.

Authors:  Ronghui Pan; Jianping Hu
Journal:  Plant Physiol       Date:  2018-01       Impact factor: 8.340

4.  Metformin ameliorates animal models of dermatitis.

Authors:  Soo Young Choi; Chanmi Lee; Min-Jeong Heo; Yeong Min Choi; In-Sook An; Seunghee Bae; Sungkwan An; Jin Hyuk Jung
Journal:  Inflammopharmacology       Date:  2020-04-28       Impact factor: 4.473

5.  Regulation of Metabolism by Mitochondrial MUL1 E3 Ubiquitin Ligase.

Authors:  Lucia Cilenti; Rohit Mahar; Jacopo Di Gregorio; Camilla T Ambivero; Matthew E Merritt; Antonis S Zervos
Journal:  Front Cell Dev Biol       Date:  2022-06-29

6.  UBXN7 cofactor of CRL3KEAP1 and CRL2VHL ubiquitin ligase complexes mediates reciprocal regulation of NRF2 and HIF-1α proteins.

Authors:  Jacopo Di Gregorio; Lucia Cilenti; Camilla T Ambivero; Thomas Andl; Ronglih Liao; Antonis S Zervos
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-01-12       Impact factor: 4.739

Review 7.  Regulation of PRKN-independent mitophagy.

Authors:  Petra Terešak; Ana Lapao; Nemanja Subic; Patricia Boya; Zvulun Elazar; Anne Simonsen
Journal:  Autophagy       Date:  2021-02-25       Impact factor: 16.016

Review 8.  NRF2 and p53: Januses in cancer?

Authors:  Barak Rotblat; Gerry Melino; Richard A Knight
Journal:  Oncotarget       Date:  2012-11

9.  Synergistic effect of two E2 ubiquitin conjugating enzymes in SCF(hFBH1) catalyzed polyubiquitination.

Authors:  Jeong-Hoon Kim; Jin Sun Choi; Sunhong Kim; Kidae Kim; Pyung Keun Myung; Sung Goo Park; Yeon-Soo Seo; Byoung Chul Park
Journal:  BMB Rep       Date:  2015-01       Impact factor: 4.778

10.  DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.

Authors:  Y M Choi; K B Kim; J H Lee; Y K Chun; I S An; S An; S Bae
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.